Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer (Q33356272)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18667090

retrieved

26 July 2017

title

Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18667090

retrieved

26 July 2017

main subject

chemotherapy

1 reference

based on heuristic

inferred from title

author

Alessandra Bearz

object named as

Alessandra Bearz

series ordinal

2

0 references

author name string

Francesca Russo

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18667090

retrieved

26 July 2017

Gianni Pampaloni

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18667090

retrieved

26 July 2017

Investigators of Italian Pemetrexed Monotherapy of NSCLC Group

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18667090

retrieved

26 July 2017

language of work or name

English

0 references

publication date

31 July 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18667090

retrieved

26 July 2017

published in

BMC Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18667090

retrieved

26 July 2017

volume

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18667090

retrieved

26 July 2017

page(s)

216

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18667090

retrieved

26 July 2017

cites work

Advances in chemotherapy of non-small cell lung cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

retrieved

14 July 2018

Review of the pemetrexed and gemcitabine combination in patients with advanced-stage non-small cell lung cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

retrieved

14 July 2018

Salvage therapy for advanced non-small cell lung cancer: factors influencing treatment selection

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

retrieved

14 July 2018

Second-line treatment for advanced-stage non-small-cell lung cancer: current and future options.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

retrieved

14 July 2018

Clinical activity of pemetrexed: a multitargeted antifolate anticancer agent

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

retrieved

14 July 2018

Optimizing first-line treatment options for patients with advanced NSCLC.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

retrieved

14 July 2018

Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

retrieved

14 July 2018

Improving survival and reducing toxicity with chemotherapy in advanced non-small cell lung cancer : a realistic goal?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

retrieved

14 July 2018

Global cancer statistics, 2002

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

retrieved

14 July 2018

Overview of phase I/II pemetrexed studies

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

retrieved

14 July 2018

Pemetrexed: its promise in treating non-small-cell lung cancer.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

retrieved

14 July 2018

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

retrieved

14 July 2018

A systematic overview of chemotherapy effects in non-small cell lung cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

retrieved

14 July 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2529337

retrieved

14 July 2018

ALIMTA (pemetrexed disodium) as second-line treatment of non-small-cell lung cancer: a phase II study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2407-8-216

retrieved

21 January 2018

Phase II Study of Pemetrexed With and Without Folic Acid and Vitamin B12 as Front-Line Therapy in Malignant Pleural Mesothelioma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1186%2F1471-2407-8-216

retrieved

21 January 2018

Chemotherapy for advanced non-small-cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18667090

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18667090

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1186/1471-2407-8-216

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18667090

retrieved

26 July 2017

Dimensions Publication ID

1016027326

0 references

PMC publication ID

2529337

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18667090

retrieved

26 July 2017

PubMed publication ID

18667090

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18667090

retrieved

26 July 2017

ResearchGate publication ID

23137507

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33356272&oldid=2195277900"